Última Hora:          Para más noticias, haga clic aquí.

Zona de Acceso
       
       
¿Recordarme? 

Busque más análisis técnicos aquí en nuestro foro: Análisis Técnicos
Nota: Los datos después de 2016-11-21 son temporales y pueden tener un valor de Apertura incorrecto hasta nueva actualización...
Cambiar para Gráfico Estático de SANOFI

Bajada de
-0,760 (-0.93%%) SANOFI - [Ticker: SAN.PA]Gráfico SANOFI  Noticias SANOFI  Descargar Históricos de Metastock SANOFI y Otros  Análisis Técnico SANOFI  
Última Transacción80,530Hora de Cotización2017-11-01 - 21:36:00
Variación-0,760 (-0.93%)Rango 52 Semanas[0,000 - 0,000]
Máximo81,990Mínimo80,430
Volumen2.902.429Volumen Medio (3m)0
Demanda / Oferta71,120 x 1.000 - 71,740 x 44.000Yield
Cierre Anterior81,290PER0,00%
Apertura81,790EPS0,00
Fecha Ex-DividendoFecha Dividendo
Capitalización Bursátil0 Objetivo Estimado 1 Año0,000
Nota: Los datos pueden tener un retraso de algunos minutos.

 Noticias de SANOFI [SAN.PA]:   (ordenadas por relevancia)

Heraldo de México (Comunicado de prensa) (blog)

México exportará vacunas de influenza a AL con 3ª planta de Sanofi ...
Heraldo de México (Comunicado de prensa) (blog)
MÁS ALLÁ DE la desconfianza que se respira en el contexto del cambio gubernamental a la vuelta de la esquina, hay rubros para los que se espera un mayor énfasis por la visión social de Andrés Manuel López Obrador. Uno de ellos es salud, afectado con ...

y más »

Farmacéutica francesa Sanofi establecerá instituto de investigación ...
Xinhua
SHANGHAI, 21 nov (Xinhua) -- La gigantesca firma farmacéutica francesa Sanofi está planeando establecer su primer instituto de investigación en China, en la ciudad oriental de Suzhou, para expandir más su presencia en el país más poblado del mundo.

y más »

L'Usine Digitale

Sanofi utilise la réalité virtuelle pour former ses opérateurs avant ...
L'Usine Digitale
Comment faire en sorte que des ouvriers soient opérationnels sur les lignes de production dès l'ouverture d'une usine ? En les formant sur une version virtuelle de cette dernière. C'est l'un des cas d'usage que présente l'entreprise pharmaceutique ...


Les Inrocks

LesInrocks - François Ruffin dénonce les ?petits arrangements entre ...
Les Inrocks
Le géant pharmaceutique Sanofi participe à une exposition au Grand Palais ?sous le haut patronage? de l'Elysée. François Ruffin y voit une preuve de plus de la ...
Dépakine: «complicité entre l'Etat et Sanofi» (Ruffin)Le Figaro

los 19 artículos informativos »

Midwest Expositor

Global Low Molecular Weight Heparin Market 2018 Overview ...
Midwest Expositor
Global Low Molecular Weight Heparin market competition by top manufacturers/players includes: , Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng ...

y más »

Endpoints News

Sanofi: European Medicines Agency recommends fexinidazole, the ...
GlobeNewswire (press release)
The positive opinion is the result of a 10-year partnership between the Drugs for Neglected Diseases initiative (DNDi), Sanofi and African partners Fexinidazole will support international efforts to eliminate sleeping sickness, a fatal neglected ...
Sanofi teams with non-profit on a landmark new drug for sleeping ...Endpoints News
European advisory group backs Sanofi's fexinidazole for sleeping ...Seeking Alpha
No more sleeping sickness; experts embrace Fexinidazole pillMyjoyonline.com

los 25 artículos informativos »

FDA grants Sanofi Pasteur's dengue vaccine priority review
Healio
Dengvaxia ? the world's only approved dengue vaccine ? is already licensed in many countries, including the Philippines, where controversy erupted and a nationwide vaccination campaign was suspended late last year after Sanofi Pasteur announced that ...

y más »

The Boston Globe

Protesters at Sanofi in Cambridge decry high price of insulin
The Boston Globe
Two mothers Friday tried to deliver the ashes of their two diabetic children to the Cambridge offices of drug giant Sanofi to protest the high price of insulin, which the company manufactures. The women said their adult children died while rationing ...

y más »

Bloomberg

Sanofi Q3 2018 Performance Confirms Return to Growth
GlobeNewswire (press release)
Sanofi Genzyme sales up 36.1% (14.9% at CER/CS(4)) driven by Immunology and Rare Blood Disorder franchises. Vaccines delivered solid growth with sales up 8.2%, supported by the Pentaxim® recovery. CHC sales increased 4.1% with growth across all ...
Sanofi Lifts Forecast as Vaccines, Eczema Drug Provide FuelBloomberg
Vaccines and Genzyme help Sanofi keep promise of return to growthReuters
Dupixent helps put Sanofi back on growth trackPMLiVE
MarketWatch -The Pharma Letter -FiercePharma
los 20 artículos informativos »

PharmaTimes

Sanofi buys into Denali's RIPK1 programme
PharmaTimes
Sanofi is linking with Denali Therapeutics on the development of multiple molecules with the potential to treat a range of neurological and systemic inflammatory diseases. The two lead molecules in the collaboration - DNL747 and DNL758 - target a ...
Buoyant Sanofi signs Denali dealThe Pharma Letter
Sanofi and Denali Therapeutics to develop treatments for ...GlobeNewswire (press release)
Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for ...Genetic Engineering & Biotechnology News
European Biotechnology
los 32 artículos informativos »

Sanofi and Regeneron's Dupixent gets more positive feedback from ...
Reuters
PARIS (Reuters) - The U.S. Food & Drug Administration (FDA) regulator has given more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday. Dupixent was launched in ...

y más »

PMLiVE

CHMP backs Sanofi's all-oral sleeping sickness drug
PMLiVE
A new drug that could revolutionise the treatment of millions of people with trypanosomiasis ? commonly known as sleeping sickness ? has been backed for approval in the EU. Sanofi's Fexinidazole Winthrop (fexinidazole) now has a positive opinion from ...

y más »

Sanofi, Denali Therapeutics in $1-Billion Deal for Neurologic Drugs
Pharmaceutical Technology Magazine
Sanofi announced plans to collaborate with Denali Therapeutics, a San Francisco, CA-based biopharmaceutical company focused on neurodegenerative diseases, in a deal potentially worth more than $1 billion to develop multiple molecules with the ...

y más »

Sanofi holds China Health Road Symposium at CIIE
PRNewswire (press release)
SHANGHAI, Nov. 13, 2018 /PRNewswire/ -- At the first China International Import Expo, Sanofi, the world's leading healthcare company, said during the China Health Road Symposium, that with Innovation, Partnership and Commitment as the three key words, ...

y más »

Marea Informative (blog)

Shares in the Spotlight: Sanofi (NYSE:SNY)
Herdon Gazette
Checking in on some recent market action, we have noted that shares of Sanofi (NYSE:SNY) have been seen trading around the $44.77 mark. Investors might be taking a closer look at these shares over the next few days. Staying on top of the current ...
Wells Fargo & Company MN Sells 948105 Shares of Sanofi SA ...Marea Informative (blog)
Sanofi SA (SNY) Position Raised by Crossmark Global Holdings Inc.Fairfield Current
Loeb Partners Corp Bought 1500 Shares of Sanofi SA (SNY)BharataPress
Stock News Oracle -Baseball Daily News -Wallstreet Investorplace
los 62 artículos informativos »
Para más noticias de SANOFI hacer clic aquí:
Noticias de SANOFI 


Anchura de la Página:

 Imagen de Fondo:

Copyright@2009-2021 - BolsaES.com, todos los derechos reservados.
Foro de Bolsa Cotizaciones Noticias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters